Skip to main content

Recent Scientific Presentations


  • Discovery of TAK-960: an Orally Available Small Molecule Inhibitor of Polo-Like Kinase 1 (Plk1)
    Zhe Nie
    242nd ACS National Meeting, August 28, 2011 Denver, CO
  • Developing an Analytical Methods Platform to Support ADCs - Finding the Optimal Antibody Drug Combination
    Mike Buckley
    World ADC Summit, February 21, 2011 Frankfurt, Germany
  • The Influence of Antigen, Antibody and ADC Properties in In Vitro and In Vivo Cytotoxicity
    Gregory Landes
    Antibody Drug Products Meeting at CHI PepTalk, January 10, 2011 San Diego, CA


  • Development of New Chiral Chromatographic Methods for the Analysis and Purification of Pharmaceutical Samples
    Lu Zeng
    Chirality 2010, July 11 -15, 2010 Sapporo, Japan
  • Discovery of NesinaTM, a Potent DPP-4 Inhibitor for the Treatment of Diabetes Mellitus Type 2, using Structural Enzymology Approaches
    Kathleen Aertgeerts
    EMBO Conference Series: Catalytic Mechanisms by Biological Systems: at the interface between chemistry and biology, May 7, 2010 Hamburg, Germany
  • Fragment-based discovery of TAK-901, a novel multi-targeted Aurora B kinase inhibitor
    Ron de Jong
    101st AACR Annual Meeting, April 17-21, 2010 Washington, DC
  • Antibody Target Discovery
    Mary Haak-Frendscho
    4 Annual Proteins Congress, April 4th, 2010 London, England